Betalfa 150mg Injection

Product Overview

About Betalfa 150mg Injection

Betalfa 150mg Injection is a sterile pharmaceutical preparation formulated for clinical use. This medicine is classified as an antimalarial agent designed to address specific parasitic infections. It is administered via the intramuscular route by qualified healthcare professionals in a controlled medical environment. The product is manufactured to meet rigorous quality standards to ensure stability and efficacy for its intended therapeutic application. Patients should only receive this treatment under the direct supervision of a licensed physician who can monitor the progress of the infection and adjust the treatment plan as necessary based on individual clinical requirements.

Key Benefits & Uses

• Indicated for the treatment of severe malaria cases.
• Effective against specific strains of Plasmodium parasites.
• Provides a targeted approach to managing acute malarial symptoms.

Active Ingredient & Action

The active ingredient in Betalfa 150mg Injection is Alpha-Beta Arteether. This compound belongs to the artemisinin derivative class of medications. It functions by interacting with the iron-containing heme within the parasite, leading to the production of free radicals that damage the parasite's cellular structures and ultimately inhibit its survival.

Important Notes

This medication is intended for professional medical administration only. Do not attempt self-administration. Ensure that your healthcare provider is fully informed of your medical history and any current medications before starting treatment. Store the product according to the specific temperature requirements provided on the packaging to maintain its chemical integrity.